---
title: "Kura Oncology to Report First Quarter 2026 Financial Results"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285200075.md"
description: "On May 5, 2026, Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company focusing on precision medicines for cancer treatment, revealed that it is set to disclose its financial results for the first quarter of 2026 post the closure of U.S. financial markets on May 12, 2026. The management of Kura will conduct a webcast and conference call at 4:30 p.m. ET / 1:30 p.m. PT on the same day to delve into the financial outcomes and present a corporate update."
datetime: "2026-05-05T11:33:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285200075.md)
  - [en](https://longbridge.com/en/news/285200075.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285200075.md)
---

# Kura Oncology to Report First Quarter 2026 Financial Results

On May 5, 2026, Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company focusing on precision medicines for cancer treatment, revealed that it is set to disclose its financial results for the first quarter of 2026 post the closure of U.S. financial markets on May 12, 2026. The management of Kura will conduct a webcast and conference call at 4:30 p.m. ET / 1:30 p.m. PT on the same day to delve into the financial outcomes and present a corporate update.

### Related Stocks

- [KURA.US](https://longbridge.com/en/quote/KURA.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)

## Related News & Research

- [NeOnc Advances Glioma Programs and Strengthens Financial Position](https://longbridge.com/en/news/286826865.md)
- [Relay drug shows early promise against rare blood vessel diseases](https://longbridge.com/en/news/287094432.md)
- [BioMarin's drug shows significant growth gains in children in late-stage trial](https://longbridge.com/en/news/287121584.md)
- [Eton Pharmaceuticals Adds Another 2026 Launch As It Secures U.S. Rights To IMPAVIDO](https://longbridge.com/en/news/287025596.md)
- [<![CDATA[Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates]]>](https://longbridge.com/en/news/286787081.md)